Eli Lilly and Company has partnered with OpenAI to leverage OpenAIs generative AI technology for developing new antimicrobial treatments to combat drugresistant pathogens Antimicrobial resistance
Shanghai Junshi Biosciences Co Ltd a leading biopharmaceutical company focused on innovation has received approval from Chinas National Medical Products Administration
Porton Advanced has recently integrated the MaxCyte cGMPgrade ExPERT GTx Flow Electroporation instrument into its cell therapy platform making it the first cell therapy CDMO in China
ILiAD Biotechnologies LLC a biotechnology company focused on combating diseases caused by Bordetella
Biond Biologics Ltd a clinicalstage biopharmaceutical company specializing in cancer immunotherapy has initiated its firstinhuman clinical trial of BND a humanized ILTLILRB antagonist antibody The trial commenced with the dosing of its first patient at the Institute of Oncology Davidoff Center Rabin...
GSK plc announced today that Omjjara has received approval from Japans Ministry of Health Labour and Welfare for treating myelofibrosis Omjjara is an oral inhibitor of JAKJAK and activin A receptor type
Hyundai Bioscience which is preparing for a dengue fever basket clinical trial in Brazil announced on the th that it has successfully developed a multitreatment drug for mosquitoborne viral infections
Capricor Therapeutics a biotechnology company developing transformative cell and exosomebased therapeutics for the treatment of rare diseases today announced
Charles River Laboratories International Inc and the Gates Institute at the University of Colorado Anschutz Medical Campus today announced a lentiviral vector contract development and manufacturing
BioAI an emerging biotech company applying multimodal artificial intelligence to novel biomarker
Bota Bio a global industrial biotechnology company specializing in sustainable biomanufacturing solutions and NHU a global leader in the fine chemical industry have announced the successful commercialization
Sun Pharmaceutical Industries Limited today announced the successful completion of the merger of Taro Pharmaceutical Industries Ltd with its subsidiary As part of this merger Sun Pharma acquired all outstanding ordinary shares of Taro other than the shares already held by Sun Pharma or its affiliate...
Incheon, South Korea
Suntec Convention & Exhibition Centre, Singapore
Basel, Switzerland
Boston, MA, USA
Singapore
Tokyo, Japan
Boston, MA, USA
Jakarta Barat, Indonesia
Professor, Chuo University
Assistant Professor, King Abdulaziz University
Department of Cell and Molecular Biology, Iladevi Cataract And IOL Research Centre
Department of Cell and Molecular Biology, Iladevi Cataract and IOL Research Centre
Department of Zoology, BMTC, Human Genetics, USSC, Gujarat University
Assistant Professor, Department of Pharmacology, Delhi Pharmaceutical Sciences and Research University
Associate Professor, Department of Biology, Khalifa University
Junaid Kashir is an Associate Professor in the Department of Biology at Khalifa University andhas previously chaired multiple researchadministrative committees He has been heavilyinvolved in multiple programs for training graduate clinical embryology students Dr Kashirsresearch aims to develop therapeuticdiagnostic interventions to treat infertility and understandembryologyAs the global pharma industry continues its shift towards precision medicine in the quest for targeting undruggable targets research and development activities have experienced a tremendous surge
Antiseizure medications are the mainstay of therapy in the management of epilepsy and are indicated for patients who have experienced two or more unprovoked seizures or a single unprovoked seizure accompanied
AbstractOne of the major challenges in the medical domain today is how to exploit the huge amount of data that this field generates To do this approaches are required that are capable of discovering knowledge that is useful for decision making in the medical field Time series are data types that are common in the medical domain and require specialized analy
Pepscan announced that there is an important progress with a drug development program based on its CLIPS technologyBicycle Therapeutics team in the UK applied Pepscans CLIPS technology to identify a bicyclic CLIPS peptide that selectively binds to a protein MTMMP present on tumor cellsA toxin payload has been linked to the high affinity bicyclic peptide to cre...
SummaryA laboratorys daytoday operations are recorded through STARLIMS accumulating data over time This data includes sample lifecycle information and metadata A range of insights can be measured from this data This includes calculation of the average time it takes to perform a task analysis of the breakdown of patient condition by age group dat
Approximately million people worldwide are living with a rare disease and about half of those affected by rare diseases are children
Although less well known than other drug development phases human factors engineering HFE is critical to meeting regulatory expectations for drugdevic...
Drug development has transformed immeasurably over the past decade Even before the Covid pandemic and the conflict in Ukraine
Many advanced largescale AI initiatives still need to be proved successful in Pharma
Singapore has had a multidecade longterm vision for building a worldclass biomedical cluster